Ondine Biomedical Inc. (OBI.L)
GBp 8.13
(4.84%)
GBp 8.13
(4.84%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 3.64 Million CAD | -25.91% |
| 2022 | 4.92 Million CAD | 9.86% |
| 2021 | 4.48 Million CAD | -87.71% |
| 2020 | 36.46 Million CAD | 25.8% |
| 2019 | 28.98 Million CAD | 29.42% |
| 2018 | 22.39 Million CAD | 84.24% |
| 2017 | 12.15 Million CAD | 0.0% |
| 2010 | 2.25 Million CAD | 68.11% |
| 2009 | 1.34 Million CAD | -16.65% |
| 2008 | 1.6 Million CAD | -25.5% |
| 2007 | 2.15 Million CAD | 15.34% |
| 2006 | 1.87 Million CAD | 151.16% |
| 2005 | 745.6 Thousand CAD | 0.0% |
| 2003 | 233.98 Thousand CAD | 62.35% |
| 2002 | 144.12 Thousand CAD | 148.43% |
| 2001 | 58.01 Thousand CAD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 Q2 | 3.26 Million CAD | 0.0% |
| 2023 Q4 | 3.64 Million CAD | 0.0% |
| 2023 FY | 3.64 Million CAD | -25.91% |
| 2022 Q2 | 3.49 Million CAD | 0.0% |
| 2022 FY | 4.92 Million CAD | 9.86% |
| 2022 Q4 | 4.92 Million CAD | 0.0% |
| 2021 Q2 | 39.27 Million CAD | 0.0% |
| 2021 FY | 4.48 Million CAD | -87.71% |
| 2021 Q4 | 4.48 Million CAD | 0.0% |
| 2020 Q4 | 36.46 Million CAD | 0.0% |
| 2020 FY | 36.46 Million CAD | 25.8% |
| 2019 FY | 28.98 Million CAD | 29.42% |
| 2018 FY | 22.39 Million CAD | 84.24% |
| 2017 FY | 12.15 Million CAD | 0.0% |
| 2011 Q2 | 4.21 Million CAD | 54.93% |
| 2011 Q1 | 2.72 Million CAD | 20.7% |
| 2010 Q3 | 1.95 Million CAD | -1.42% |
| 2010 Q1 | 1.7 Million CAD | 26.75% |
| 2010 FY | 2.25 Million CAD | 68.11% |
| 2010 Q2 | 1.97 Million CAD | 16.45% |
| 2010 Q4 | 2.25 Million CAD | 15.55% |
| 2009 Q4 | 1.34 Million CAD | 10.7% |
| 2009 FY | 1.34 Million CAD | -16.65% |
| 2009 Q1 | 1.62 Million CAD | 1.28% |
| 2009 Q3 | 1.21 Million CAD | -23.45% |
| 2009 Q2 | 1.58 Million CAD | -2.88% |
| 2008 Q4 | 1.6 Million CAD | 13.18% |
| 2008 FY | 1.6 Million CAD | -25.5% |
| 2008 Q1 | 1.55 Million CAD | -28.0% |
| 2008 Q2 | 1.48 Million CAD | -4.22% |
| 2008 Q3 | 1.42 Million CAD | -4.55% |
| 2007 Q3 | 2.26 Million CAD | 3.51% |
| 2007 Q4 | 2.15 Million CAD | -4.75% |
| 2007 Q2 | 2.19 Million CAD | 33.35% |
| 2007 Q1 | 1.64 Million CAD | -12.27% |
| 2007 FY | 2.15 Million CAD | 15.34% |
| 2006 FY | 1.87 Million CAD | 151.16% |
| 2006 Q4 | 1.87 Million CAD | 13.83% |
| 2006 Q3 | 1.64 Million CAD | 5.17% |
| 2006 Q2 | 1.56 Million CAD | 43.69% |
| 2006 Q1 | 1.08 Million CAD | 46.02% |
| 2005 Q1 | 525.62 Thousand CAD | 16.69% |
| 2005 Q4 | 745.6 Thousand CAD | -21.6% |
| 2005 Q3 | 951.03 Thousand CAD | 19.95% |
| 2005 Q2 | 792.85 Thousand CAD | 50.84% |
| 2005 FY | 745.6 Thousand CAD | 0.0% |
| 2004 Q3 | 606.93 Thousand CAD | -19.04% |
| 2004 Q2 | 749.66 Thousand CAD | -58.44% |
| 2004 Q1 | 1.8 Million CAD | 699.29% |
| 2004 Q4 | 450.45 Thousand CAD | -25.78% |
| 2003 Q4 | 225.68 Thousand CAD | -3.55% |
| 2003 FY | 233.98 Thousand CAD | 62.35% |
| 2003 Q1 | 168.43 Thousand CAD | 11.43% |
| 2003 Q3 | 233.98 Thousand CAD | 17.68% |
| 2003 Q2 | 198.83 Thousand CAD | 18.05% |
| 2002 FY | 144.12 Thousand CAD | 148.43% |
| 2002 Q2 | 134.8 Thousand CAD | 45.32% |
| 2002 Q3 | 144.12 Thousand CAD | 6.92% |
| 2002 Q4 | 151.15 Thousand CAD | 4.87% |
| 2002 Q1 | 92.76 Thousand CAD | 17.16% |
| 2001 Q4 | 79.17 Thousand CAD | 0.0% |
| 2001 FY | 58.01 Thousand CAD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|